Citadel Advisors’s Invivyd IVVD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.6K Buy
27,000
+13,700
+103% +$17.2K ﹤0.01% 13367
2026
Q1
$17.3K Sell
13,300
-35,700
-73% -$65.6K ﹤0.01% 12699
2025
Q4
$121K Sell
49,000
-51,200
-51% -$106K ﹤0.01% 11489
2025
Q3
$110K Buy
+100,200
New +$88.9K ﹤0.01% 11780
2025
Q2
Sell
-18,900
Closed -$11.4K 13799
2025
Q1
$11.4K Buy
18,900
+16,800
+800% +$15.1K ﹤0.01% 13488
2024
Q4
$931 Hold
2,100
﹤0.01% 14252
2024
Q3
$2.14K Buy
2,100
+1,500
+250% +$1.63K ﹤0.01% 13774
2024
Q2
$660 Sell
600
-11,700
-95% -$25.9K ﹤0.01% 13938
2024
Q1
$54.6K Buy
12,300
+11,600
+1,657% +$47.9K ﹤0.01% 12090
2023
Q4
$2.76K Buy
+700
New +$1.32K ﹤0.01% 13661
2023
Q3
Sell
-700
Closed -$735 14691
2023
Q2
$735 Sell
700
-300
-30% -$383 ﹤0.01% 14055
2023
Q1
$1.2K Sell
1,000
-24,200
-96% -$44.2K ﹤0.01% 14344
2022
Q4
$37.8K Sell
25,200
-1,100
-4% -$3.06K ﹤0.01% 12480
2022
Q3
$82K Sell
26,300
-48,100
-65% -$192K ﹤0.01% 11258
2022
Q2
$244K Sell
74,400
-2,000
-3% -$6.27K ﹤0.01% 10269
2022
Q1
$348K Buy
76,400
+58,200
+320% +$356K ﹤0.01% 10248
2021
Q4
$132K Buy
+18,200
New +$473K ﹤0.01% 12427

Other funds holding IVVD

Citadel Advisors's IVVD Position: Q2 2026 in Review

Citadel Advisors increased its Invivyd (IVVD) stake by 125% in Q2 2026, buying an estimated $2.5M and bringing the position to 3,580,941 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #5623.

Citadel Advisors first reported a position in IVVD in Q3 2021 and has held it in 16 quarters since. 125 funds tracked by Wall St. Rank hold IVVD as of Q2 2026.

  • Citadel Advisors held 3,580,941 shares of Invivyd worth $3.12M as of Q2 2026.
  • Citadel Advisors bought 1,991,366 Invivyd shares in Q2 2026, an estimated $2.5M.
  • Invivyd made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5623 holding.
  • Citadel Advisors first reported a position in Invivyd in Q3 2021 and has held it in 16 quarters since.
  • 125 funds tracked by Wall St. Rank held Invivyd as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.